Peripheral immune proteomics and public monocyte transcriptomics in neovascular AMD with inadequate response to anti-VEGF therapy: an exploratory cross-omic analysis

Objective To compare the PBMC proteome of patients with nAMD and an inadequate response to aflibercept, relative to controls without retinal pathology, with two published monocyte transcriptomic datasets, in order to quantify gene- and pathway-level concordance across molecular layers and to identify features shared across datasets. Participants and controls Twelve patients with nAMD and an inadequate response to aflibercept and 9 controls without retinal pathology were included. For cross-omic comparison, two public monocyte transcriptomic datasets were used: GSE76237, including 14 treatment-naïve patients with nAMD and 15 age-matched controls, and GSE222647, including 27 previously treated patients with nAMD stratified by anti-VEGF treatment burden (15 low-burden and 12 high-burden patients). Methods Proteomics PBMCs were profiled by data-independent acquisition LC/MS-MS. Differential abundance was assessed with limma, followed by network clustering and functional enrichment analysis. The proteomic signature was compared at gene and pathway (Hallmark) level with 2 public monocyte transcriptomic datasets: single-cell RNA sequencing (GSE222647) and microarray (GSE76237). Main outcome measures Differentially abundant protein groups and enriched pathways; overlap and directional concordance of genes and Hallmark pathways between the proteomic and transcriptomic datasets. Results Network clustering and functional enrichment consistently indicated changes in proteins of the transcription, mRNA splicing and translation machinery, together with altered abundance of mitochondrial proteins, including SMDT1 and TOMM subunits. Cross-omic comparison identified 10 and 24 genes shared with the scRNA-seq and microarray datasets, respectively, numbers consistent with chance, with directional concordance of 3/10 and 13/24. Log 2 fold changes were essentially uncorrelated across layers, and CD82 and TAOK2, the only genes shared across all three datasets, showed inconsistent direction. Hallmark enrichment scores showed no correlation across layers (15 of 48 pathways concordant). Conclusions Relative to controls without retinal pathology, the PBMC proteome of patients with nAMD and an inadequate response to aflibercept showed changes in the gene-expression machinery and altered abundance of mitochondrial proteins. This signature was not reflected in monocyte transcriptomic data. These exploratory findings identify SMDT1 and TOMM subunits as candidates for targeted validation in cohorts including patients with an adequate response to anti-VEGF therapy.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-19
DOI
https://doi.org/10.3389/fimmu.2026.2022439
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Peripheral immune proteomics and public monocyte transcriptomics in neovascular AMD with inadequate response to anti-VEGF therapy: an exploratory cross-omic analysis

María José Rodríguez‐Cid, Antonio Cañizo-Outeiriño, María Isabel Fernández-Rodríguez, Anxo Fernández‐Ferreiro et al.
Frontiers in Immunology
Retinal Diseases and Treatments
article

Peripheral immune proteomics and public monocyte transcriptomics in neovascular AMD with inadequate response to anti-VEGF therapy: an exploratory cross-omic analysis

María José Rodríguez‐Cid, Antonio Cañizo-Outeiriño, María Isabel Fernández-Rodríguez, Anxo Fernández‐Ferreiro, Pablo Almuiña-Varela, Maximino José Abraldes, Miguel González‐Barcia, María Gil‐Martínez, Ignacio Ortea, Francisco J. Javier Diaz-Corrales, Sandra Tenreiro, Jesús Mateos, Cristina Mondelo‐García, Andrea Cuartero‐Martínez, Ana García‐García, Diana Carolina Castro-Fernández, María del Pilar Méndez-Cepeda, Mariña Pena, Begoña de Domingo-Barón, María Purificación Mera-Yáñez, Francisco Gómez-Ulla
article en

Abstract

Objective To compare the PBMC proteome of patients with nAMD and an inadequate response to aflibercept, relative to controls without retinal pathology, with two published monocyte transcriptomic datasets, in order to quantify gene- and pathway-level concordance across molecular layers and to identify features shared across datasets. Participants and controls Twelve patients with nAMD and an inadequate response to aflibercept and 9 controls without retinal pathology were included. For cross-omic comparison, two public monocyte transcriptomic datasets were used: GSE76237, including 14 treatment-naïve patients with nAMD and 15 age-matched controls, and GSE222647, including 27 previously treated patients with nAMD stratified by anti-VEGF treatment burden (15 low-burden and 12 high-burden patients). Methods Proteomics PBMCs were profiled by data-independent acquisition LC/MS-MS. Differential abundance was assessed with limma, followed by network clustering and functional enrichment analysis. The proteomic signature was compared at gene and pathway (Hallmark) level with 2 public monocyte transcriptomic datasets: single-cell RNA sequencing (GSE222647) and microarray (GSE76237). Main outcome measures Differentially abundant protein groups and enriched pathways; overlap and directional concordance of genes and Hallmark pathways between the proteomic and transcriptomic datasets. Results Network clustering and functional enrichment consistently indicated changes in proteins of the transcription, mRNA splicing and translation machinery, together with altered abundance of mitochondrial proteins, including SMDT1 and TOMM subunits. Cross-omic comparison identified 10 and 24 genes shared with the scRNA-seq and microarray datasets, respectively, numbers consistent with chance, with directional concordance of 3/10 and 13/24. Log 2 fold changes were essentially uncorrelated across layers, and CD82 and TAOK2, the only genes shared across all three datasets, showed inconsistent direction. Hallmark enrichment scores showed no correlation across layers (15 of 48 pathways concordant). Conclusions Relative to controls without retinal pathology, the PBMC proteome of patients with nAMD and an inadequate response to aflibercept showed changes in the gene-expression machinery and altered abundance of mitochondrial proteins. This signature was not reflected in monocyte transcriptomic data. These exploratory findings identify SMDT1 and TOMM subunits as candidates for targeted validation in cohorts including patients with an adequate response to anti-VEGF therapy.

Frontiers in ImmunologyVol. 17
Consejo Superior de Investigaciones Científicas (ES), Universidade de Santiago de Compostela (ES), Complejo Hospitalario Universitario de Santiago (ES), Nanomaterials and Nanotechnology Research Center (ES), Instituto de Investigación Sanitaria de Santiago (ES), Centro Andaluz de Biología Molecular y Medicina Regenerativa (ES), Instituto de Investigación Sanitaria del Principado de Asturias (ES), Universidade Nova de Lisboa (PT)
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon